If coronavirus vaccines are restricted to seniors and those at high risk, parents of young children and relatives of ...

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...

The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...

The FDA will encourage new clinical trials on the widely used ... such as individuals who are prediabetic or have high blood ...

In the last few weeks, the FDA has started to limit COVID vaccine approvals, limiting their use in healthy people under 65 ...

The FDA approved Moderna’s new Covid-19 vaccine late Friday, though it placed restrictions on its use that the company’s ...

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement ...

As the Trump administration moves to limit COVID booster vaccines for some, here's what to know about the latest variant NB.1 ...

The FDA imposed similar limitations on Novavax’s Covid vaccine when it approved ... Trump administration’s call for tighter restrictions on vaccine eligibility and approvals.

The FDA approved Moderna’s lower-dose COVID-19 vaccine, but only for individuals aged 65 years or older and people aged 12 to ...

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...

That’s the same limit that the FDA set in licensing another COVID-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines ...